Therefore, we may propose that mitochondria is one of the targeted subcellular organels in cardiomyocytes affected by insulin resistance and they could respond to the treatment of SGLT2 inhibitors [42, 51]. The gene discussed is SLC5A2; the disease is Insulin resistance.